Cost-effectiveness of moderate-to-severe psoriasis treatment.

  title={Cost-effectiveness of moderate-to-severe psoriasis treatment.},
  author={Drew W Miller and Steven R. Feldman},
  journal={Expert opinion on pharmacotherapy},
  volume={7 2},
Psoriasis is a common, chronic inflammatory disease that can cause as much disability as cancer, diabetes or other major medical illnesses. Traditional therapies for treating moderate-to-severe psoriasis include phototherapy, methotrexate, oral retinoids and ciclosporin. New biological treatments provide further therapeutic options, but add to the already considerable cost of managing psoriasis. Expert panels have published guidelines for the use of biological agents in managing moderate-to… CONTINUE READING


Publications citing this paper.
Showing 1-10 of 23 extracted citations

The Costs of Psoriasis Medications

View 4 Excerpts
Highly Influenced

Phototherapy in dermatology: A call for action.

Journal of the American Academy of Dermatology • 2015
View 1 Excerpt

Research gaps in psoriasis: opportunities for future studies.

Journal of the American Academy of Dermatology • 2014
View 1 Excerpt

Similar Papers

Loading similar papers…